US: 1.646.568.9797 (24x5)
UK: 44.330.808.0580 (24x5)
Worldwide: 91.703.051.960 (24x7)
“Global Conjugate Vaccines Market Analysis Trends, Applications, Analysis, Growth, and Forecast to 2028” is a recent report generated by Trusted Business Insights. The global conjugate vaccines market report has been segmented on the basis of type, disease indication, pathogen type, end user, and region. Request Covid - 19 Impact Global Conjugate Vaccines Market: Overview Conjugate vaccines are vaccines contains bacterial capsule polysaccharide and used for infectious diseases. It improves immunogenic property of polysaccharide. Such types of vaccines are used to immunize infants and children against invasive disease which are caused by Streptococcus pneumoniae, Neisseria meningitidis, H. influenzae, and Hib bacteria. Conjugate vaccines are currently in use for children against pneumococcal bacterial infections are made using this technique. Global Conjugate Vaccines Market: Dynamics Increasing government initiatives across various countries, technological advancements, improvement in vaccine formulation, and rising incidences of infectious diseases are major factors expected to drive growth of the global market over the forecast period. In addition, rising investment in research and development activities by key players operating in the target market, increasing demand for vaccination, and increasing preference towards immunization programs are some other factors expected to further fuel the growth of the target market over the forecast period. Moreover, an increasing the number of health awareness programs in order to promote vaccination and prevention of infectious diseases is another factor expected to boost the growth of the target market over the forecast period. However, lack of availability in remote areas and the lengthy and difficult production process of conjugate vaccines are major factors expected to restrain the growth of the global market over the forecast period. Increasing research and development activities for the development of technologically advanced and innovative products and development of strategic business activities such as mergers, acquisitions, etc. are expected to create lucrative opportunities for the global market over the forecast period. Global Conjugate Vaccines Market: Segment Analysis Among the type segments, the monovalent conjugate vaccines segment is expected to register significant growth in terms of revenue over the forecast period, owing to rising awareness and availability of high-quality vaccines by manufacturers in this market. Among the disease indication segments, the diphtheria-tetanus and pertussis segment is expected to register a significant share in terms of revenue over the forecast period, owing to its high prevalence. Global Conjugate Vaccines Market: Regional Analysis The market in North America is expected to dominate in the global market over the forecast period, owing to increasing demand for meningococcal, pneumococcal vaccines, and related conjugate vaccines across various countries in this region. Is estimated to cause about 900,000 pneumococcal pneumonia infections within the United States per year, resulting in 450,000 hospitalizations which is the most common cause of community-acquired pneumonia (CAP) in the United States. Emerging resistance to antibiotics is increasing and community-acquired pneumonia is a frequent and severe infection and is the eighth most common cause of overall mortality in the United States. S. pneumonia an opportunistic pathogen that takes advantage of hosts with underdeveloped, weakened, and or deteriorating immune systems and has the greatest incidence rates in children under the age of two, the immunocompromised, and the elderly The market in Europe is expected to register second-highest growth in terms of revenue over the forecast period, owing to increasing government focus on research and availability of funds for research and development activities across various countries in this region. The market in Asia Pacific is expected to register significant growth in terms of CAGR over the forecast period, owing to increasing government initiatives, rising initiatives by various organizations such as World Health Organization and GAVI across various countries in this region. Global Conjugate Vaccines Market Segmentation: Segmentation by type: Monovalent Conjugate Vaccines Multivalent Conjugate Vaccines Segmentation by disease indication: Pneumococcal Influenza Diphtheria Tetanus and Pertussis (DTP) Meningococcal Others Segmentation by pathogen type: Bacterial Conjugate Vaccine Viral Conjugate Vaccine Combination (Viral and Bacterial) Conjugate Vaccine Segmentation by end user: Pediatrics Adults
Table of Contents Chapter 1. Methodology and Scope 1.1. Research Methodology 1.2. Research Scope & Assumptions 1.3. List of Data SourcesChapter 2. Executive SummaryChapter 3. Global Conjugate Vaccines Market Outlook 3.1. Market Segmentation 3.2. Market Size and Growth Prospects, 2016 - 2027 3.3. Value Chain Analysis 3.4. Market Dynamics 3.4.1. Market driver analysis 3.4.2. Market restraint analysis | read more...